Cellebrite DI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	475.68	401.2	325.11	270.65	246.25
Revenue Growth (YoY)	18.56%	23.41%	20.12%	9.91%	26.34%
Cost of Revenue	75.17	62.59	53.23	50.75	42.56
Gross Profit	400.5	338.61	271.88	219.91	203.69
Selling, General & Admin	220.15	183.29	154.26	138.24	124.33
Research & Development	113.88	98.42	84.39	80.62	65.54
Total Operating Expenses	334.02	281.7	238.64	218.86	189.87
Operating Income	66.48	56.91	33.24	1.04	13.82
Total Non-Operating Income (Expense)	24.2	-332.89	-108.8	119.72	68.48
Pretax Income	90.68	-275.98	-75.56	120.76	82.31
Provision for Income Taxes	12.35	7.02	5.54	-0.05	10.91
Net Income	78.33	-283.01	-81.1	120.81	71.4
Net Income to Common	78.33	-283.01	-81.1	120.81	71.4
Net Income Growth	-	-	-	69.20%	1135.01%
Shares Outstanding (Basic)	242	209	190	183	144
Shares Outstanding (Diluted)	250	209	190	195	162
Shares Change (YoY)	19.30%	10.16%	-2.68%	20.96%	-16.45%
EPS (Basic)	0.32	-1.35	-0.43	0.64	0.49
EPS (Diluted)	0.31	-1.35	-0.43	0.59	0.44
EPS Growth	-	-	-	34.09%	-
Free Cash Flow	160.32	123.61	96.83	13.68	30.94
Free Cash Flow Growth	29.70%	27.66%	607.80%	-55.79%	-48.71%
Free Cash Flow Per Share	0.64	0.59	0.51	0.07	0.19
Gross Margin	84.20%	84.40%	83.63%	81.25%	82.72%
Operating Margin	13.98%	14.18%	10.22%	0.39%	5.61%
Profit Margin	16.47%	-70.54%	-24.95%	44.63%	28.99%
FCF Margin	33.70%	30.81%	29.78%	5.05%	12.57%
EBITDA	78.35	67.51	43.25	10.24	20.83
EBITDA Margin	16.47%	16.83%	13.30%	3.78%	8.46%
EBIT	66.48	56.91	33.24	1.04	13.82
EBIT Margin	13.98%	14.18%	10.22%	0.39%	5.61%
Effective Tax Rate	13.62%	-2.54%	-7.33%	-0.04%	13.25%

Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q